Chalmers, James D.
Tebboth, Abigail
Gayle, Alicia
Ternouth, Andrew
Ramscar, Nick
Article History
Received: 10 October 2016
Revised: 22 May 2017
Accepted: 25 May 2017
First Online: 29 June 2017
Competing interests
: J.D.C. has received funding from the Wellcome Trust, Medical Research Council, Chief Scientist Office, Scottish Government, Tenovus Scotland, Bayer HealthCare, European Respiratory Society, AstraZeneca, Basilea, GlaxoSmithKline, Boehringer Ingelheim, Napp Pharmaceuticals, Pfizer and Chiesi. Ab.T., A.G., and An.T. are employees of Boehringer Ingelheim, the study sponsor. N.R. was an employee of Boehringer Ingelheim at the time of involvement in the study.
: Methods were performed in accordance with relevant regulations/guidelines. This study was reviewed and approved by the Independent Scientific Advisory Committee for Medicines and Healthcare products Regulatory Agency database research (Ref: 15_237 R) and an internal scientific committee within the study sponsor. As this was a non-interventional study using anonymised data, no patient consent was necessary.